Journal of Advanced Pharmaceutical Science And Technology

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Advanced Pharmaceutical Science And Technology-My research interests focus on the molecular events underlying neurological diseases.-Tauheed Ishrat

united states

Department of Pharmacy,
University of Georgia

Send an Email

Tauheed Ishrat


HM-1200 Georgia Regents University Campus
1120 15th Street
Augusta, GA 30912,United States

Research Interests:

  • My research interests focus on the molecular events underlying neurological diseases.
  • In my studies I concentrate on three diseases: Parkinson, Alzheimer and Cerebral stroke.
  • The long-term goal to identify potential new drug targets for the development of causative treatments.
  • These are progressive diseases of the nervous system involving damage or loss of neurons in the brain.
  • The causes of the diseases are unknown but recent evidence suggests a multifactorial origin involving genetic and environmental factors.
  • Considerable efforts have been made to determine the cellular mechanisms that might underlie the cell death in these diseases.
  • Over the years, several pathogenic hypotheses have been proposed, including oxidative stress, apoptosis, excitotoxicity, inflammation and mitochondrial dysfunction.
  • However, up to now it is not known which of these metabolic pathways participate in the process of cell death, if and how they interact and which genes are regulating this complex network.


  • Dr. Ishrat working as a Research scientist at University of Georgia, Augusta, GA.
  • My research revolves around the importance of vascular protection in the acute stroke period to improve outcome of ischemic stroke.
  • Also, I am trying to identify tactics for decreasing vascular damage after ischemic stroke in an attempt to develop new therapies for stroke patients.